Wednesday, October 23, 2019

Intrepida Bio Gets $9.5M

San Diego-based Intrepida Bio, a biopharmaceuticals startup focused on developing medicines that modulate the innate immune system to fight cancer and other diseases, has raised $9.5M in a funding round, according to the company. The funding came from Sofinnova Investments and Canaan. According to Intrepida, the funding will go towards investigation

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.